Home › Funds › Copeland Capital Management, LLC › CHE
Copeland Capital Management, LLC position in CHE
CHEMED CORP NEW · Health Care
Copeland Capital Management, LLC reported holding 146,833 shares of CHE (CHEMED CORP NEW) in its Q3 2026 13F filing — a position valued at US$74.2M, representing 1.71% of its reported portfolio and ranking #6 among its reported holdings. Copeland Capital Management, LLC has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How Copeland Capital Management, LLC's CHE position evolved
Copeland Capital Management, LLC first disclosed a stake in CHE in Q3 2023 at 128,813 shares (US$66.9M). The position peaked in Q1 2025 at 149,035 shares, worth US$91.7M. Across 13 filings, Copeland Capital Management, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 146,833 shares valued at US$74.2M — an increase of 1,826 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 128.81K | $66.94M | New |
| Q4 2023 | 125.38K | $73.31M | Reduce |
| Q1 2024 | 128.10K | $82.23M | Add |
| Q2 2024 | 128.49K | $69.72M | Hold |
| Q3 2024 | 129.79K | $78.00M | Add |
| Q4 2024 | 151.62K | $80.33M | Add |
| Q1 2025 | 149.03K | $91.71M | Reduce |
| Q2 2025 | 146.83K | $71.50M | Reduce |
| Q3 2025 | 146.37K | $65.53M | Hold |
| Q4 2025 | 137.55K | $58.85M | Reduce |
| Q1 2026 | 147.96K | $55.89M | Add |
| Q2 2026 | 145.01K | $67.54M | Reduce |
| Q3 2026 | 146.83K | $74.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CHE and 13F data
CHE (CHEMED CORP NEW) is a Health Care company. 25 other funds we track also report a position in CHE — the largest reported positions include Epoch Investment Partners, Inc. (US$124.5M), River Road Asset Management, LLC (US$110.8M), Boston Trust Walden Corp (US$93.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CHE
- Epoch Investment Partners, Inc. 267.29K sh · $124.49M · Q2 2026
- River Road Asset Management, LLC 237.93K sh · $110.81M · Q2 2026
- Boston Trust Walden Corp 201.28K sh · $93.74M · Q2 2026
More on Copeland Capital Management, LLC
FAQ
How long has Copeland Capital Management, LLC held CHE?
Copeland Capital Management, LLC has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Copeland Capital Management, LLC's current position in CHE?
As of Q3 2026, Copeland Capital Management, LLC holds 146.83K shares of CHE (CHEMED CORP NEW), valued at $74.16M, representing 1.71% of its reported portfolio and ranking #6.
Has Copeland Capital Management, LLC been buying or selling CHE?
In the latest 13F filing (Q3 2026), Copeland Capital Management, LLC increased its position in CHE. The position peaked in Q1 2025 at 149.03K shares.
Which other funds hold CHE?
Other major institutional holders of CHE include Epoch Investment Partners, Inc., River Road Asset Management, LLC, Boston Trust Walden Corp, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.